Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.3c00457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Samarth D Thakore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Mohali, Punjab 160062, India. Hauptthemen laut MEDLINE: Water. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Department of Chemicals and Petrochemicals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Drugs have been classified as fast, moderate, and poor crystallizers based on their inherent solid-state crystallization tendency. Differential scanning calorimetry-based heat-cool-heat protocol serves as a valuable tool to define the solid-state crystallization tendency. This classification helps in the development of strategies for stabilizing amorphous drugs. However, microscopic characteristics of the samples were generally overlooked during these experiments. In the present study, we evaluated the influence of microscopic cracks on the crystallization tendency of a poorly water-soluble model drug, celecoxib. Cracks developed in the temperature range of 0-10 °C during the cooling cycle triggered the subsequent crystallization of the amorphous phase. Nanoindentation study suggested minimal differences in mechanical properties between samples, although the cracked sample showed relatively inhomogeneous mechanical properties. Nuclei nourishment experiments suggested crack-assisted nucleation, which was supported by Raman data that revealed subtle changes in intermolecular interactions between cracked and uncracked samples. Celecoxib has been generally classified as class II, i.e., a drug with moderate crystallization tendency. Interestingly, classification of amorphous celecoxib may change depending on the presence or absence of cracks in the amorphous sample. Hence, subtle events such as microscopic cracks should be given due consideration while defining the solid-state crystallization tendency of drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Mohali, Punjab 160062, India.
- Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER), Nadia, Kolkata ,West Bengal 741246, India.
- Department of Chemical Engineering, Indian Institute of Technology-Gandhinagar,Palaj, Gujarat382355, India.
ORCID-Profile: Sameer V Dalvi, C Malla Reddy, Arvind K Bansal
Förderung
- Department of Chemicals and Petrochemicals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Thakore, S. D., Das, K., Dalvi, S. V., Reddy, C. M., & Bansal, A. K. (2024). Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00457
Vancouver
Thakore SD, Das K, Dalvi SV, Reddy CM, Bansal AK. Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c00457
BibTeX
@article{Thakore2024,
author = {Thakore, Samarth D and Das, Kaustav and Dalvi, Sameer V and Reddy, C Malla and Bansal, Arvind K},
title = {Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.3c00457}
}
EUVIMED